Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Tumor
1000-7431
2012 Issue 8
zhong liu za zhi gao yue
..............page:660-661
Docosahexaenoic acid enhances the sensitivity of human gastric cancer SGC-7901 cells to adriamycin
YANG Yi-ju; SUN Zhen-qiu Department of Social Medicine and Health Service Management; School of Public Health; Central South University; Changsha 410083; China
..............page:599-604
Research progress in the factors associated with Helicobacter pylori-related gastric carcinogenesis
QIAN Jin; FANG Jing-yuan Department of Digestive Diseases; Renji Hospital; Shanghai Jiaotong University School of Medicine; Shanghai Institution of Digestive Diseases; Shanghai 200001; China
..............page:650-653
Effects of all-trans retinoic acid combined with gamma radiation on proliferation and apoptosis of esophageal carcinoma TE13 cells
DENG Qiu-yuan1; 2; DONG Zhi-ming2 1. Department of General Internal Medicine; Huazhong Agricultural University Hospital; Wuhan 430070; China; 2. Pathology Laboratory of Hebei Cancer Institute; Fourth Hospital of Hebei Medical University; Shijiazhuang 050011; China
..............page:592-598
The regulatory effect of ginsenoside Rg3 on expression of somatostatin receptor in lung carcinoma allografts in mice and its significance
HE Jian-bin; LIAO Hui-zhong; YI Gao-zhong; CHEN Zhi-kui; HE Wei Department of Respiratory Diseases; Huaihua First People’s Hospital; Huaihua 418000; Hunan; China
..............page:572-577
Targeted gene silencing of homo sapiens eukaryotic translation elongation factor 1 alpha 2 inhibits migration and invasion of human pancreatic cancer cell line BxPC-3 in vitro
XU Chao; HU Duan-min; ZHU Qi Department of Gastroenterology; Ruijin Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200025; China
..............page:567-571
The dynamic change of CD133 expression in chemical-induced liver carcinogenesis in mice
TANG Chao-li1; KUANG Zhi-peng2; YANG Fan2; WU Ji-ning2 1. Graduate School of Guangxi Medical University; Nanning 530021; China; 2. Department of Experimental Research; Cancer Hospital; Guangxi Medical University; Nanning 530021; China
..............page:585-591
Expressions of HIF-1α and VEGF in rhabdomyosarcoma and their clinical significance
TONG Gang-ling1; SUN Xiao-fei2; ZHEN Zi-jun2; LIN Lin3 1. Department of Medical Oncology; Shenzhen Hospital; Peking University; Shenzhen 518036; Guangdong; China; 2. Department of Pediatric Oncology; Cancer Center; Sun Yat-sen University; Guangzhou 510060; China; 3. Department of Medical Oncology; Shenzhen Second People’s Hospital; Shenzhen 518035; Guangdong; China
..............page:634-638
Expressions of tumor stem cell markers EpCAM and CD133 in human primary hepatocellular carcinoma and their value in prognostic prediction
PAN Qun-xiong; SU Zi-jian; WANG Cong-ren; ZHUANG Jian-liang Department of Oncosurgery; Quanzhou First Hospital; Fujian Medical University; Quanzhou 362000; Fujian; China
..............page:628-633
Comparison of the 7th and 6th edition AJCC TNM staging systems for gastric cancer: analysis of prognosis in a retrospective review of 918 patients at a single institution in China
SONG Wei-feng; YAO Li-jun; QIU Zheng-jun; WANG Li-wei Department of Medical Oncology; Shanghai First People’s Hospital; Shanghai Jiaotong University; Shanghai 200080; China
..............page:615-621
The trends of female breast cancer incidence and mortality in Beijing, Shanghai, Linzhou and Qidong in China
HUANG Zhe-zhou1; CHEN Wan-qing2; WU Chun-xiao1; ZHENG Rong-shou2; CHEN Jian-guo3; CHENG Lan-ping4; WANG Ning5; ZHANG Si-wei2; ZHENG Ying1 1. Department of Cancer Control & Prevention; Shanghai Municipal Center for Disease Control and Prevention; Shanghai 200336; China; 2. National Office for Cancer Prevention and Control; Cancer Hospital & Institute; Chinese Academy of Medical Sciences; Beijing 100021; China; 3. Qidong Liver Cancer Institute; Qidong 226200; Jiangsu; China; 4. Linzhou Tumor Hospital; Linzhou 456550; Henan; China; 5. Beijing Institute for Cancer Research; Beijing 100142; China
..............page:605-608
Correlation between serum CA15-3 level and the molecular subtypes of metastatic breast cancer
SHAO Jun; PAN Cui-ping; MA Biao Department of Breast Cancer; Hubei Cancer Hospital; Wuhan 430079; China
..............page:639-642
Analysis of clinicopathological features and prognostic factors of patients with metastatic breast cancer
YU Qian; TONG Zhong-sheng; WANG Xu; SHI Ye-hui; HE Li-hong; LIU Xiao-dong Department of Breast Medical Oncology; Tianjin Medical University Cancer Institute and Hospital; Ministry of Education Key Laboratory of Breast Cancer Prevention and Therapy; Tianjin Key Laboratory of Cancer Prevention and Therapy; Tianjin 300060; China
..............page:609-614
Retrospective analysis of clinical characteristics and prognosis of 30 patients misdiagnosed and mistreated for osteosarcoma
QIAO Guang-lei; QI Wei-xiang; ZHENG Shui-er; MIN Da-liu; SHEN Zan; YAO Yang Department of Medical Oncology; Sixth People’s Hospital; Shanghai Jiaotong University; Shanghai 200233; China
..............page:622-627
Differential serum peptide profiling of patients with bone metastasis from primary hepatocellular carcinoma using MALDI-TOF-MS
CHEN Bing; HE Jian; ZENG Zhao-chong; DU Shi-suo; YANG Ping Department of Radiation Oncology; Zhongshan Hospital; Fudan University; Shanghai 200032; China
..............page:643-649
Gene silencing by lentivirus-mediated delivery of integrin β4 shRNA inhibits the growth of subcutaneous xenografts of human non-small cell lung carcinoma H460SM cells in nude mice
CHEN Yan1; YANG Gui-mei2; ZHOU Yong-chun1; LIU Xin1; JIN Cong-guo1; CHEN Xiao-qun1; LI Jia1; WANG Xi-cai1 1. Yunnan Tumor Institute/Tumor Hospital of Yunnan Province; Third Affiliated Hospital of Kunming Medical University; Kunming 650118; China; 2. School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products; Kunming Medical University; Kunming 650500; China
..............page:578-584
The role of p21-activated kinases in cancer and targeted therapy
LU Wen; WAN Xiao-ping Department of Obstetrics and Gynecology; International Peace Maternity & Child Health Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200030; China
..............page:654-658